Novo Integrated Sciences Provides Update on Certain Current Events
Upon completion of the Collateral transfer, the Company expects to leverage the Collateral in order to obtain a significant line of credit.
- Upon completion of the Collateral transfer, the Company expects to leverage the Collateral in order to obtain a significant line of credit.
- The line of credit would be secured solely by the Collateral, leaving the balance of the Company’s assets free and clear.
- Upon successful monetization, the Company will advance the prescribed fee of 15% of the monetization amount to Blacksheep Trust.
- In short order Novo Integrated Sciences Inc. will be granted the right of first draw against the coupon resulting in a more significant role for RC as it relates to ensuring a good compliance standing.